Intermediate filament protein inclusions

Methods in Cell Biology

Volumn 2004, Issue 78, 2004, Pages 205-228

  Zatloukal, Kurt ^a   Stumptner, Conny ^a   Fuchsbichler, Andrea ^a   Janig, Elke ^a   Denk, Helmut ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; EPITOPE; INTERMEDIATE FILAMENT PROTEIN; KERATIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; CELL INCLUSION; CHO CELL; FLUORESCENCE MICROSCOPY; GENETICS; HAMSTER; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER CELL; MALE; METABOLISM; MOUSE; MOUSE MUTANT; ULTRASTRUCTURE;

ANIMALS; ANTIBODIES; CELLS, CULTURED; CHO CELLS; CRICETINAE; EPITOPES; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; INTERMEDIATE FILAMENT PROTEINS; KERATINS; MALE; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MICROSCOPY, IMMUNOELECTRON; MODELS, BIOLOGICAL;

EID: 14244262401     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(04)78008-5     Document Type: Review

References (50)

1. Angulo, P. (2002). Nonalcoholic fatty liver disease. N. Engl. J. Med. 16, 1221-1231.
2. Bardag-Gorce, F., Riley, N., Nguyen, V., Montgomery, R. O., French, B. A., Li, J., van Leeuwen, F. W., Lungo, W., McPhaul, L. W., and French, S. W. (2003). The mechanism of cytokeratin aggresome formation: The role of mutant ubiquitin (UBB+1). Exp. Mol. Pathol. 74, 160-167.
3. Baribault, H., Penner, J., Iozzo, R. V., and Wilson-Heiner, M. (1994). Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 8, 2964-2974.
4. Cadrin, M., French, S. W., and Wong, T. T. (1991). Alternation in molecular structure of cytoskeleton proteins in griseofulvin-treated mouse liver: A pressure tuning infrared spectroscopy study. Exp. Mol. Pathol. 55, 170-179.
5. Denk, H., Gschnait, F., and Wolff, K. (1975). Hepatocellular hyalin (Mallory bodies) in long term griseofulvin-treated mice: A new experimental model for the study of hyalin formation. Lab. Invest. 32, 773-776.
6. Denk, H., Krepler, R., Lackinger, E., Artlieb, U., and Franke, W. W. (1982). Immunological and biochemical characterization of the keratin-related component of Mallory bodies: A pathological pattern of hepatocytic cytokeratins. Liver 2, 165-175.
7. Denk, H., Stumptner, C., and Zatloukal, K. (2000). Mallory body revisited. J. Hepatol. 32, 689-702.
8. Dinges, H. P., Zatloukal, K., Denk, H., Smolle, J., and Mair, S. (1992). Alcoholic liver disease. Parenchyma to stroma relationship in fibrosis and cirrhosis as revealed by three-dimensional reconstruction and immunohistochemistry. Am. J. Pathol. 141, 69-83.
9. Ehrnsperger, M., Gräber, S., Gaeste, M., and Buchner, J. (1997). Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J. 16, 221-229.
10. Franke, W. W., Denk, H., Schmid, E., Osborn, M., and Weber, K. (1979). Ultrastructural, biochemical and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides. Lab. Invest. 40, 207-220.
11. Fuchs, E., and Weber, K. (1994). Intermediate filaments: Structure, dynamics, function, and disease. Annu. Rev. Biochem. 63, 345-382.
12. Goebel, H. H. (1997). Desmin-related myopathies. Curr. Opin. Neurol. 10, 426-429.
13. Grune, T., Reinheckel, T., and Davies, K. J. A. (1997). Degradation of oxidized proteins in mammalian cells. FASEB J. 11, 526-534.
14. Hartl, F. U. (1996). Molecular chaperones in cellular protein folding. Nature 381, 571-580.
15. Kazan, R., Denk, H., Franke, W. W., Lackinger, E., and Schiller, D. L. (1986). Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab. Invest. 54, 543-553.
16. Herrmann, H., Hesse, M., Reichenzeller, M., Aebi, U., and Magin, T. M. (2003). Functional complexity of intermediate filament cytoskeletons: From structure to assembly to gene ablation. Int. Rev. Cytol. 223, 83-175.
17. Hershko, A., and Ciechanover, A. (1998). The ubiquitan system. Annu. Rev. Biochem. 67, 425-479.
18. lck- associated protein in response to oxidative stress. Biochem. Biophys. Res. Comm. 226, 456-460.
19. Johnston, J. A., Ward, C. L., and Kopito, R. R. (1998). Aggresomes: A cellular response to misfolded proteins. J. Cell Biol. 143, 1883-1898.
20. lck SH2 domain. Proc. Natl. Acad. Sci. USA 93, 5991-5995.
21. Julien, J-P. (1997). Neurofilaments and motor neuron disease. Trends Cell Biol. 7, 243-249.
22. Ku, N-O., and Omary, M. B. (2000). Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J. Cell Biol. 149, 547-552.
23. Liao, J., Ku, N. O., and Omary, M. B. (1997). Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at ser-73 in tissues and cultured cells. J. Biol. Chem. 272, 17565-17573.
24. Lieber, C. S. (2000). Alcoholic liver disease: New insights in pathogenesis lead to new treatments. J. Hepatol. 32, 113-128.
25. Lowe, J., Blanchard, A., Morell, K., Lennox, G., Reynolds, L., Billet, M., Landon, M., and Mayer, R. J. (1988). Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J. Pathol. 155, 9-15.
26. Lowe, J., McDermott, H., Pike, I., Spendlove, I., Landon, M., and Mayer, R-J. (1992). Alpha B crystallin expression in non-lenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease. J. Pathol. 166, 61-68.
27. Magin, T. M., Schröder, R., Leitgeb, S., Wanninger, F., Zatloukal, K., Grund, C., and Melton, D. W. (1998). Lessons from keratin 18 knockout mice: Formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J. Cell Biol. 140, 1441-1451.
28. Omary, B. M., Ku, N. O., and Toivola, D. M. (2002). Keratins: Guardians of the liver. Hepatology 35, 251-257.
29. Ohta, M., Marceau, N., Perry, G., Manetto, V., Gambetti, P., Autilio-Gambetti, L., Metuzals, J., Kawahara, H., Cadrin, M., and French, S. W. (1988). Ubiquitin is present on the cytokeratin filaments and Mallory bodies of hepatocytes. Lab. Invest. 59, 848-856.
30. Pollanen, M. S., Dickson, D. W., and Bergeron, C. (1993). Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52, 183-191.
31. Sanz, L., Sanchez, P., Lallena, M-J., Diaz-Meco, M. T., and Moscat, J. (1999). The interaction of p62 with RIP links the atypical PKCs to NF-κB activation. EMBO J. 18, 3044-3053.
32. Shin, J. (1998). p62 and the sequestosome, a novel mechanism for protein metabolism. Arch. Pharm. Res. 21, 629-633.
33. Sherman, M. Y., and Goldberg, A. L. (2001). Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases. Neuron 29, 15-32.
34. Stumptner, C., Fuchsbichler, A., Lehner, M., Zatloukal, K., and Denk, H. (2001). Sequence of events in the assembly of Mallory body components in mouse liver: Clues to the pathogenesis and significance of Mallory body formation. J. Hepatol. 34, 665-675.
35. Stumptner, C., Heid, H., Fuchsbichler, A., Hauser, H., Mischinger, H-J., Zatloukal, K., and Denk, H. (1999). Analysis of intracytoplasmatic hyaline bodies in a hepatocellular carcinoma: demonstration of p62 as a major constituent. Am. J. Pathol. 154, 1701-1710.
36. Stumptner, C., Omary, M. B., Fickert, P., Denk, H., and Zatloukal, K. (2000). Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a Mallory body mouse model. Am. J. Pathol. 156, 77-90.
37. Tephly, T. R., Coffman, B. L., Ingall, G., Abou Zeit-Har, M. S., Golf, H. M., Tabba, H. D., and Smith, K. M. (1981). Identification of N-methylprotophorphyrin IX in lives of untreated mice and mice treated with 3,5-diethoxycarbonyl-1,4-dihydrocollidine: Source of the methyl group. Arch Biochem. Biophys. 212, 120-126.
38. Tsunoo, C., Harwood, T. R., Arak, S., and Yokoo, H. (1987). Cytoskeletal alterations leading to Mallory body formation in livers of mice fed 3,5-diethoxycarbonyl-1,4-dihydrocollidine. J. Hepatol. 5, 85-97.
39. lck, belongs to a new class of ubiquitin-binding proteins. J. Biol. Chem. 271, 20235-20237.
40. Van Eyken, P., Sciot, R., and Desmet, V. L. (1988). A cytokeratin immunohistochemical study of alcoholic liver disease: Evidence that hepatocytes can express "bile duct-type" cytokeratins Histopathology 13, 605-617.
41. Vickers, J. C., Dickson, T. C., Adlard, P. A., Saunders, H. L., King, C. E., and McCormack, G. (2000). The cause of neuronal degeneration in Alzheimer's disease. Prog. Neurobiol. 60, 139-165.
42. Wisniewski, T., and Goldman, J. E. (1998). αB-crystallin is associated with intermediate filaments in astrocytoma cells. Neurochem. Res. 23, 385-392.
43. Westendorf, J. M., Rao, P. N., and Gerace, L. (1994). Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc. Natl. Acad. Sci. USA 91, 714-718.
44. Yokoo, H., Minick, O. T., Batti, F., and Kent, G. (1972). Morphologic variants of alcoholic hyalin. Am. J. Pathol. 69, 25-40.
45. Yuan, O. X., Nagao, Y., French, B. A., Wan, Y. J. Y., and French, S. W. (2000). Dexamethasone enhances Mallory body formation in drug-primed mouse liver. Exp. Mol. Pathol. 69, 202-210.
46. Zatloukal, K., Boeck, G., Rainer, I., Denk, H., and Weber, K. (1991). High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Lab. Invest. 64, 200-206.
47. Zatloukal, K., Denk, H., Spurej, G., Lackinger, E., Preisegger, K-H., and Franke, W. W. (1990). High molecular weight component of Mallory bodies detected by a monoclonal antibody. Lab. Invest. 62, 427-434.
48. Zatloukal, K., Fesus, L., Denk, H., Taresa, E., Spurej, G., and Böck, G. (1992). High amount of epsilon-(gamma-glutamyl)lysine cross-links in Mallory bodies. Lab. Invest. 66, 774-777.
49. Zatloukal, K., Stumptner, C., Fuchsbichler, A., Heid, H., Schnoelzer, M., Kenner, L., Kleinert, R., Prinz, M., Aguzzi, A., and Denk, H. (2002). p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160, 255-263.
50. Zatloukal, K., Stumptner, C., Lehner, M., Denk, H., Baribault, H., Eshkind, L. G., and Franke, W. W. (2000). Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies. Am. J. Pathol. 156, 1263-1274.